Surveillance Value of Apparent Diffusion Coefficient Maps: Multiparametric MRI in Active Surveillance of Prostate Cancer

被引:3
|
作者
Georgiev, Aleksandar [1 ,2 ]
Chervenkov, Lyubomir [1 ,3 ]
Doykov, Mladen [4 ]
Doykova, Katya [1 ]
Uchikov, Petar [5 ]
Tsvetkova, Silvia [1 ]
机构
[1] Med Univ Plovdiv, Med Fac, Dept Diagnost Imaging, Bul Vasil Aprilov 15A, Plovdiv 4002, Bulgaria
[2] Complex Oncol Ctr Plovdiv, Dept Diagnost Imaging, ul Pere Toshev 62, Plovdiv 4004, Bulgaria
[3] Med Univ Plovdiv, Res Complex Translat Neurosci, Bul Vasil Aprilov 15A, Plovdiv 4002, Bulgaria
[4] Med Univ Plovdiv, Med Fac, Dept Urol & Gen Med, Bul Vasil Aprilov 15A, Plovdiv 4002, Bulgaria
[5] Med Univ Plovdiv, Med Fac, Dept Special Surg, Bul Vasil Aprilov 15A, Plovdiv 4002, Bulgaria
关键词
prostate cancer; screening; imaging; surveillance; mp-MRI;
D O I
10.3390/cancers15041128
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Prostate cancer is one of the leading oncological diseases in the male population. Early detection and treatment of the disease gives better survival chances and a better long-term prognosis. The aim of this study is to establish the value of magnetic resonance imaging sequences for the detection and active surveillance of prostate cancer. The collected data from 530 patients indicate that the apparent diffusion coefficient (ADC) is the most specific and sensitive magnetic resonance sequence. Therefore, we advocate for its inclusion in the routine scanning protocol for prostate cancer. We advise on at least a bi-parametric magnetic resonance that includes apparent diffusion coefficient and a T2 sequence. Background: This study aims to establish the value of apparent diffusion coefficient maps and other magnetic resonance sequences for active surveillance of prostate cancer. The study included 530 men with an average age of 66, who were under surveillance for prostate cancer. We have used multiparametric magnetic resonance imaging with subsequent transperineal biopsy (TPB) to verify the imaging findings. Results: We have observed a level of agreement of 67.30% between the apparent diffusion coefficient (ADC) maps, other magnetic resonance sequences, and the biopsy results. The sensitivity of the apparent diffusion coefficient is 97.14%, and the specificity is 37.50%. According to our data, apparent diffusion coefficient is the most accurate sequence, followed by diffusion imaging in prostate cancer detection. Conclusions: Based on our findings we advocate that the apparent diffusion coefficient should be included as an essential part of magnetic resonance scanning protocols for prostate cancer in at least bi-parametric settings. The best option will be apparent diffusion coefficient combined with diffusion imaging and T2 sequences. Further large-scale prospective controlled studies are required to define the precise role of multiparametric and bi-parametric magnetic resonance in the active surveillance of prostate cancer.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] The role of whole-lesion apparent diffusion coefficient analysis for predicting outcomes of prostate cancer patients on active surveillance
    Tsutomu Tamada
    Hasan Dani
    Samir S. Taneja
    Andrew B. Rosenkrantz
    Abdominal Radiology, 2017, 42 : 2340 - 2345
  • [32] Multiparametric prostate MRI and MRI/ultrasound fusion biopsy as tools to follow prostate cancer progression for men on active surveillance
    Shakir, Nabeel
    Walton-Diaz, Annerleim
    Rais-Bahrami, Soroush
    Turkbey, Baris
    Rothwax, Jason
    Hong, Cheng William
    Stamatakis, Lambros
    George, Arvin
    Okoro, Chinonyerem
    Raskolnikov, Dima
    Siddiqui, Minhaj
    Su, Daniel
    Simon, Richard
    Wood, Bradford J.
    Choyke, Peter L.
    Pinto, Peter A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [33] Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer
    An, Julie Y.
    Sidana, Abhinav
    Choyke, Peter L.
    Wood, Bradford J.
    Pinto, Peter A.
    Turkbey, Ismail Baris
    BALKAN MEDICAL JOURNAL, 2017, 34 (05) : 388 - 396
  • [34] Is there an impact of the center performing baseline multiparametric MRI on active surveillance outcomes in prostate cancer patients?
    Leni, R.
    Stabile, A.
    Gandaglia, G.
    Mazzone, E.
    Cucchiara, V
    Rosiello, G.
    Sorce, G.
    Robesti, D.
    De Angelis, M.
    Scuderi, S.
    Cannoletta, D.
    Brembilla, G.
    Esposito, A.
    De Cobelli, F.
    Montorsi, F.
    Briganti, A.
    EUROPEAN UROLOGY, 2023, 83
  • [35] IS THERE AN IMPACT OF THE CENTER PERFORMING BASELINE MULTIPARAMETRIC MRI ON ACTIVE SURVEILLANCE OUTCOMES IN PROSTATE CANCER PATIENTS?
    Leni, Riccardo
    Stabile, Armando
    Gandaglia, Giorgio
    Cucchiara, Vito
    Rosiello, Giuseppe
    Mazzone, Elio
    Sorce, Gabriele
    Pellegrino, Francesco
    Scuderi, Simone
    Robesti, Daniele
    Cannoletta, Donato
    De Angelis, Mario
    Quarta, Leonardo
    Zaurito, Paolo
    Brembilla, Giorgio
    De Cobelli, Francesco
    Montorsi, Francesco
    Briganti, Alberto
    JOURNAL OF UROLOGY, 2023, 209 : E528 - E528
  • [36] MULTIPARAMETRIC MRI OUTPERFORMS PSA VELOCITY FOR PATHOLOGIC PROGRESSION IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER
    Kongnyuy, Michael
    George, Arvin
    Siddiqui, Minhaj
    Muthigi, Akhil
    Kadakia, Meet
    Frye, Thomas
    Sidana, Abhinav
    Kilchevsky, Amichai
    Han, Hui
    Mertan, Francesca
    Su, Daniel
    Merino, Maria
    Turkbey, Baris
    Choyke, Peter
    Wood, Bradford
    Pinto, Peter
    JOURNAL OF UROLOGY, 2016, 195 (04): : E158 - E159
  • [37] HETEROGENEITY IN DETECTION RATES OF HIGHER GRADE PROSTATE CANCER BY MULTIPARAMETRIC MRI IN AN ACTIVE SURVEILLANCE COHORT
    Mamawala, Mufaddal
    Landis, Patricia
    Macura, Katarzyna
    Epstein, Jonathan
    Carter, H. Ballentine
    JOURNAL OF UROLOGY, 2018, 199 (04): : E205 - E205
  • [38] Combined utility of PSA density and multiparametric MRI in predicting progression on active surveillance for prostate cancer
    Kalapara, A.
    Wang, L.
    Fahey, M.
    Frydenberg, M.
    BJU INTERNATIONAL, 2019, 123 : 44 - 45
  • [39] MRI and active surveillance for low risk prostate cancer [MRI en active surveillance voor laagrisicoprostaatkanker]
    van den Bergh R.C.N.
    Meijer R.P.
    Heijmink S.W.
    van der Poel H.G.
    Tijdschrift voor Urologie, 2014, 4 (8) : 185 - 191
  • [40] MULTIPARAMETRIC PROSTATE MRI AND MRI/ULTRASOUND FUSION BIOPSY IN THE FOLLOW-UP OF PROSTATE CANCER PROGRESSION FOR MEN ON ACTIVE SURVEILLANCE
    Walton-Diaz, Annerleim
    Shakir, Nabeel
    Rais-Bahrami, Soroush
    Turkbey, Baris
    Rothwax, Jason
    George, Arvin
    Siddiqui, Minhaj
    Okoro, Chinonyerem
    Raskolnikov, Dima
    Hong, William Cheng
    Su, Daniel
    Stamatakis, Lambros
    Han, Hui
    Simon, Richard
    Wood, Bradford
    Choyke, Peter
    Pinto, Peter
    JOURNAL OF UROLOGY, 2014, 191 (04): : E346 - E347